BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24885312)

  • 1. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p73 locus is commonly deleted in non-Hodgkin's lymphomas.
    Stoffel A; Filippa D; Rao PH
    Leuk Res; 2004 Dec; 28(12):1341-5. PubMed ID: 15475076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
    Morin RD; Mendez-Lago M; Mungall AJ; Goya R; Mungall KL; Corbett RD; Johnson NA; Severson TM; Chiu R; Field M; Jackman S; Krzywinski M; Scott DW; Trinh DL; Tamura-Wells J; Li S; Firme MR; Rogic S; Griffith M; Chan S; Yakovenko O; Meyer IM; Zhao EY; Smailus D; Moksa M; Chittaranjan S; Rimsza L; Brooks-Wilson A; Spinelli JJ; Ben-Neriah S; Meissner B; Woolcock B; Boyle M; McDonald H; Tam A; Zhao Y; Delaney A; Zeng T; Tse K; Butterfield Y; Birol I; Holt R; Schein J; Horsman DE; Moore R; Jones SJ; Connors JM; Hirst M; Gascoyne RD; Marra MA
    Nature; 2011 Jul; 476(7360):298-303. PubMed ID: 21796119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of non-Hodgkin's lymphoma.
    Nogai H; Dörken B; Lenz G
    J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.
    Schmitz R; Renné C; Rosenquist R; Tinguely M; Distler V; Menestrina F; Lestani M; Stankovic T; Austen B; Bräuninger A; Hansmann ML; Küppers R
    Leukemia; 2005 Aug; 19(8):1452-8. PubMed ID: 15973455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
    Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
    Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
    Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
    Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
    Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
    Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".
    Kledus F; Filip D; Mráz M
    Klin Onkol; 2023; 36(4):353-363. PubMed ID: 37877527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
    Matolcsy A; Casali P; Warnke RA; Knowles DM
    Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
    Almasri NM; Al-Alami J; Faza M
    Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
    Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
    Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
    Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.